Philip Morris
Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
Fields
- Author
- Rose, M.A.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Named Organization
- Methodist Hospital Cancer Center
- Named Person
- Rose, M.A.
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Author (Organization)
- Cancer Nursing
- Methodist Hospital Cancer Center
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
Csaeec Nutaag' 1M5) 2_5--3 1991. C 1991 Raven ?ress. Ltd.. rew t ork
'
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Intervention strategies
for smoking cessation
The role of oncology nursing
Marilee A. Rose, R.N., M.S.
The role of oncology nurses concerned with the health
effects of cigarette smoking may often be defined as
dealing with the morbidity and mortality associated
with tobacco use-caring for individuals diagnosed
with tobacco-related malignancies. As current treat-
ment methods of many of these malignancies offer
little hope of cure, oncology nurses need to diverge
from these traditional roles and include a focus on
primary prevention activities. An essential component
of these activities is a knowledge of smoking cessation
education strategies and an understanding of the
methods that motivate and arsist individuals to quit
smoking.
Key Words: Smoking cessation interventions-,Role
of oncology nursing--"Patient education.
There are numerous ways of explicitly stating
the health hazards tdateci to smoking. Smoking is
responsible for more than one of every six deaths in
Marike Rox nuar of Oncolop Ctinial Research,
Methodist Hospll~Centa. Minneapolis. Minnesota.
Address correspondafce and ceprint rqquats to NuiJee A. Rose,
Coadinator Oncoiop Resarch: MethodisyHc~it~! Cattoer,
Center.!5Q0, Facalsio~ F~~ard, p O. $bc 650:!Minnapolisl MN
3544ok
Acoepted for pubiiation May 2Z. 199t.
the United States (1). Cigarette smoking is the single
greatest cause of preventable death and disability in
the nation (2). Cigarette smoking is responsible for,
83% of lung cancer cases and acx~unts for about 30%
of all cancer deaths (3). The economic implications
of smoking are overwhelming. The U.S. Congress,
Office of Technology Assessment has estimated the
total of smoking-related health care costs and lost
productivity costs at approximately $65 billion dollars
each year (4). There is growing recognition of the
health risks associated with passive smoking or the
inhalation of smoke from the tobacco products of
others (5). Scientific evidence has established the
involuntary inhalation of tobacco smoke as a causative
factor in diseases and death among nonsmokers.
According to the National Research Cauncil, every
year, 2,500-8,400 of the > 12,000 lung cancer deaths
in the United States not due to smoking may be
attributable to environmental tobacco smoke (6).
Scientific and public knowledge of the health
consequences of smoking, and programs and pQlicies
that encourage nonsmoking behavior have iri~
significantly since 1964 (1). Approximatel}c three-
quarters of a million smoking-related deat#,s' were
avoided or postponed between 1964 and 198~ as a
result of decisions to quit smoking or not to 'atart.
These decisions will also result in the postponement
or avoidance of an estimated 2.1 million smoking-
225

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
226
M. A. ROSE
related deaths between 1986 and the year 2000.
Although >50 million Americans continue to smoke,
>90 million would be smoking in the absence of the
changes in the smoking and health environment that
have occurred since 1964.
Understanding the methods for motivating and
assisting individuals to quit smoking is essential for
all health professionals (7). It is imperative that
oncology nurses become familiar with smoking ces-
sation education and adept in the methods to assist
individuals with quitting in order to effectively influ-
ence the morbidity and mortality associated with
smoking. Oncology nurses can influence smoking
behaviors in a variety of settings and populations.
The opportunity exists in outpatient treatment or
screening clinics, hospital patient care areas, support
groups, family education, and interactions with co-
workers and friends. The intent of this article is to
increase the awareness of the need and purpose for
smoking cessation education within oncology patient
care settings and to provide an overview of current
smoking cessation education strategies.
SMOKING CESSATION ASSISTANCE AFTER
A CANCER DIAGNOSIS
Knowledge of effective smoking cessation inter-
ventions for patients with cancer is limited. Many
false assumptions and attitudes exist regarding the
necessity and importance of addressing smoking ces-
sation among cancer patients such as, "all people
who are diagnosed with cancer automatically quit
smoking" or "what is the benefit of quitting for
someone diagnosed with cancer?"
A recent survey of >2,500 cancer patients ad-
mitted to M. D. Anderson Hospital showed a current
smoking rate of 34.6% for men and 31.8% for women
(8). The preliminary results of a National Cancer
Institute Cooperative study designed to evaluate
smoking patterns and cessation interventions in early
stage cancer patients within 1 year of the initial
diagnosis found a smoking rate of 17% (9). Oncology
nurses may often see patients who make an attempt
to quit smoking at the time of diagnosis, but relapse
rates are high. Davison (10) studied the smoking
habits of long-term lung cancer survivors and reported
that 56% of the patients who smoked had stopped
prior to their surgery, but the majority resumed
smoking within 1 year of diagnosis.
Although smoking cessation after the diagnosis
of inetastatic or advanced cancer may have limited
benefits and may create an unnecessary burden for
Canoer KwtrRr. Vol. 1!. No. 3.1991
patients with a poor prognosis. there are multiple
reasons to advocate smoking cessation among patienu
who have the potential for cure (11-15).
1. Reduced risk of disease recurrence
2. Reduced risk of heart and lung disease and
second malignancies
3. Improvements in therapy tolerance
4. Decreased risk of pulmonary infections
5. Improvement of lung and cardiac function
6. Improved quality of life
There is a reduced risk for future malignancies.
Tobacco use is strongly implicated in the development
of subsequent malignancies and increases the risk of
disease recurrence in persons with cancers of the head
and neck (12,13). Moore (12) followed 203 patients
who had been cured of cancer of the oral cavity,
pharynx, or larynx, and reported that 40% of patients
who continued to smoke developed second cancers,
compared to a 6% rate of recurrence among patients
who had stopped smoking. Smoking has been asso-
ciated with more rapid development of metastasis in
women over 50 years of age with breast cance: ( I4).
Because cigarette smoking affects multiple organs,
smoking cessation will decrease the risk of respiratory
and cardiovascular disease among long-term survivors
and also may reduce the risk of developing second
malignancies. Patients will experience improvements
in therapy tolerance such as improved sleep, appetite,
sense of taste and smell, and energy level. In a survey
of patients with lung cancer, those who stopped
smoking felt that the benefits of quitting contributed
to an improved quality of life (15). Cigarette smoking
causes excessive secretions and a predisposition to
pulmonary infections. Cancer patients who smoke
will continue to compromise their fespiratory and
cardiac function. This is critical for patients whose
lung or cardiac function may already be compromised
by resectional thoracic surgeries, infections, chemo-
therapy agents with pulmonary or cardiac toxicities,
or chest irradiation.
There are several factors potentially complicating
smoking cessation for patients with cancer (8). The
lack of perceived health benefits once a cancer is
diagnosed may be experienced. Many patients are
extremely nicotine dependent and often have impair-
ments that make chewing nicotine gum difficult or
impossible. Patients often have strong defensein{ech-
anisms such as denial to justify their conti4ued
smoking. The stress of the diagnosis and treatment
make trying to quit smoking very difficult. Wle
are dealing with a life-threatening illness; thercfore.
~
C'?
O
~
~
©

INTERVENTION STRATEGIES FOR SMOKING CESSATIOh'
I
I
I
I
I
smoking cessation may not be a high priority for
many individuals.
The preliminary results of a National Cancer
Institute (NCI) cooperative study in early stage cancer
patients are very positive and speak to the need to
address smoking cessation in this population (9).
Approximately 1,300 patients in outpatient oncology
settings were asked to complete a smoking question-
naire. Of the 625 eligible participants, 66% expressed
a strong belief in the personal benefits of quitting,
over two-thirds expressed a strong desire to quit or
were seriously considering stopping smoking in the
next 6 months, and over three-fourths were interested
in materials to help them quit.
INTERVENTION STRATEGIES
Ninety-five peteent of American ex-smokers have
quit on their own (16). What does "quitting on your
own" really mean? It is usually not just a one-time
thought with immediate success. These words can be
misleading, sending the message that stopping smoking
is a simple and easy thing to do without any assistance.
People who "quit on their own" are motivated by
mass media antismoking messages, policies that re-
strict smoking, and taxation that increases the price
of cigarettes. People who "quit on their own" get
assistance and support from friends, family, coworkers,
medical personnel, and self-help materials.
Self-help manuals provide step-by-step instruc-
tions for the preparations and planning necessary to
make quit attempts more tolerable and successful.
They are available from many organizations either
free or for a minimal charge, including Freedom
From Smoking For You and Your Family from the
American Lung Association, Clearing the Air from
the NCI, and the Patieru Stop Smoking Guide from
the American Academy of Family Physicians
(17-19).
Physicians and other health care professionals
have the opportunity to deliver widespread smoking
cescation interventions. In the U.S., approximately
75% of adults visit a physician at least once annually;
the average number of physician-patient contacts per
year is five (20). There is convincing evidence that
physicians can influence their patients to stop smok-
ing. A study by Russell in England demonstrated that
5 min of physician advice about the importance of
stopping smoking accompanied by educational ma-
terials and a warning about follow-up produced 1-
year quit rates of -5% (21). There is an increased
adherence to advice to quit smoking during a serious
or life-threatening illness, particularly if the symptonis
are smoking-related (7,20). Nurses can also effectively
influence patients to quit smoking by providing similar
motivational advice or reinforcing physician advice
and providing formal education and smoking cessation
counseling. A study by Taylor et al. (22) concludt.t that a nurse-managed, hospital-based smoking
cessa-
tion intervention program significantly reduced
smoking rates in patients who had had a myocardial
infarction.
Several factors act as barriers to physician in-
volvement with smoking cessation (16,23,24).
1. Pessimism about the ability of patients' to
quit smoking or influence a change in behav-
ior
2. Counseling is an unfamiliar role
3. Lack of training and knowledge of resources
4. Infringement on personal freedom
5. Lack of time
6. Lack of reimbursement
In my experience, similar barriers are also strongly
evident among nurses. The first barrier is a pessimistic
attitude of patients' ability to quit smoking or the
ability to influence a change in smoking behavior.
The evidence shows that health care professionals
can influence patients to stop smoking even with
very brief and concise interventions. In order to keep
a positive outlook, reasonable goals for success should
be established (7,23). It would be unrealistic to expect
that any intervention will result in 100% quit rates.
A second barrier is the belief that counseling is not
part of the physician or nurse role. Complex coun-
seling is not necessary for most smokers; direct advice
and motivation are more helpful. Third is the lack
of training and knowledge of resources. Yet simple
protocols can be designed and incorporated into office
routines. Infringement on personal freedom is another
barrier. Physicians and nucses may feel that they do
not want to embarrass their patients or discourage
them from returning. The failure to ask about smoking
can be interpreted by the patient as a sign that
quitting smoking is not important or may send a
pessimistic message about the belief in the patient's
ability to quit. Lack of time can be a barr}et. even
though smoking status can be determined ~ith a
single question, "Do you use tobacco?." and it only
takes a few minutes to deliver a quit smoking"F"SageA final barrier is the lack of reimbursement.
Although
the lack of-third party reimbursement for preventive
health is often a reality, creative ways must be found
to provide smoking cessation education to patients.
I
I
I
I
I
I
1
I
I
I
I
I
Caacrr NwstRC. I iW !4. No. S. 1991
I

??8 M. A. ROSE
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
PROVIDING EFFECTIVE EDUCATION
How can we motivate and assist persons to quit
smoking? The message to quit smoking must be
personalized, firm, and straightforward. This message
is most effective if delivered in a positive manner,
offering resources, encouragement, understanding, and
support; criticisms, judgments, or personal attitudes
about smoking should be avoided. The role of public
health interventions is to provide information that
maximizes healthy choices and to assist persons who
are in the process of quitting. We need to be careful
not to imply moral condemnation or penalty, or
stigma in our educational efforts to help people stop
smoking.
Our interventions may be most effective when
w,! try to understand the perspective of individuals
«no smoke and are trying to quit. Ninety percent of
the people who smoke would like to quit, and 60%
have tried (23). Smoking is a strongly reinforced
habit! If an individual averages 10 puffs per cigarette
and has smoked 1 pack per day for 10 years, they
have had 730,000 hits of nicotine, and a person who
has smoked 2 packs per day for 20 years has puffed
on a cigarette nearly 3,000,000 times (19). In 1988,
Surgeon General Koop issued the warning that nic-
otine is as addictive as heroin and cocaine (25).
Follow-up support is an important component
of any smoking cessation program (7,23,24,26). Many
methods can be utilized, including a scheduled follow-
up visit, a personalized letter, or a phone call. All of
these methods offer support that indicate a continued
interest in the individual and emphasize the impor-
tance of stopping smoking.
STAGES OF QUITTING
The process of becoming an ex-smoker has been
described in terms of movement through a series of
stages (27). First is the motivational stage or initial
decision, second is the stage of behavioral changes,
and third isthe maintenance stage.
Modratioml Stsp
The key motivational factor associated with suc-
crssful smoking cessation is the desire to protect
future health and overcome minor smoking-related
symptoms (23). This is the single most important
reason people have for quitting. Other factors include
a sense of personal vulnerability to smoking-related
health risks, a desire for greater self-control, self-
esteem, confidence in their ability to quit, and the
expectation of benefits from quitting such as improved
health or the elimination of social pressures.
There are many fears that people who smoke
anticipate when they are contemplating quitting
(23,24,26.28)
1. Fear of failing
2. Fear of withdrawal symptoms and unbearable
cravings
3. Fear of weight gain
4. Fear of ridicule
5. Fear of inability to relax or sleep
6. Fear of emotional changes
It is important to recognize and respond to these
fears on an individual basis. One is the fear of failing.
Fewer than 25% of smokers quit the first time they
try, most take three or four attempts (24). A second
is the fear of withdrawal symptoms and unbearable
cravings. These symptoms are transient and, more
importantly, temporary. Most urges last only 3-5
min and become less frequent over the first 7-10
days after quitting. Third, is the fear of weight gain.
Only one-third of ex-smokers gain weight and gen-
erally <10 pounds (23,24). The other two-thirds
either lose weight or maintain their weight. Weight
gain is not automatic and can be controlled by dietary
restrictions and increasing physical activity. Fourth ii
the fear of ridicule from smoking friends. This can
be countered by enlisting support from nonsmoking
friends or from others who have also quit smoking.
There is also the fear of the inability to relax or sleep
without smoking. The feeling of relaxation from
smoking is only temporary and is related to the relief
of withdrawal symptoms. Nicotine is actually a stim-
ulant. Healthier alternatives to help with relaxatior
include exercise, avoiding naps, and limiting the
amount of caffeine ingested. The fear of emotional
changes such as irritability is experienced by some.
This can be dealt with by temporarily decreasing
personal demands and learning stress reduction meth-
ods such as relaxation techniques.
Once the decision is made to stop smoking,
what are the next steps? Most important is the
identification of personal reasons for quitting. There
are many different reasons for wanting to stoQ qrnok
ing; the stronger the reasons, the better the thance:
for success. A list of personal reasons caft ~be 2
powerful reminder of the commitment to sto6 s}nok
ing later when urges to smoke are experienced. Rkea
the reasons for starting smoking. Point out that wher
people first begin smoking, it is awkward and probSN3
makes them feel sick. Becoming a smoker reQMrc.
I
I
Cairrr Nwstn". Vo(. 11, No. S. 1991

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
1
INTERVEA710N STRATEGIES FOR SMOKING CESSATION
practice. It is important to understand that smoking
is not a natural act. It is a learned behavior, therefore,
people must learn new behaviors in order to quit.
Identify the reasons for smoking now. Smoking is a
very complex behavior, people smoke at different
times for different reasons. These reasons include
psychological issues, habits, social pressures, and
physical dependence. They may vary from day to
day depending on the situation. It is important to
raise a person's awareness of what triggers their
smoking patterns. Many of the self-help manuals
available include written exercises to help individuals
identify and personalize these issues.
Behavioral Changes
There are many methods that have been used
to facilitate smoking cessation. Aversive strategies are
designed to reduce the reinforcing value of smoking
by pairing it with an aversive stimulus (28). Rapid
smoking is the method of inhaling every 6 s, whereas
the average smoker puffs at the rate of one puff per
minut.e. Satiation is the method of doubling or tripling
the normal amount of smoking. Th: possibility of
physical side effects with these me- ss limits their
application to individuals with hea,. .-;roblems or to
pregnant women.
Gradual re3uction and nicotine fading are meth-
ods that decrease the physiological addiction to nic-
otine and decrease withdrawal symptoms (23,28).
With gradual reduction, persons gradually reduce the
number of cigarettes they smoke until a predetermined
quit date. A potential problem with this method is
that initially it is easiest to eliminate cigarettes that
are the least rewarding and enjoyable, and as the
tapering occurs, persons are left with the cigarettes
they enjoy the most. These last few cigarettes can
become very powerful reinforcers and can be very
difficult to give up. Nicotine fading is the process of
switching brands gradually to lower levels of tar and
nicotine. The rationale for this method is that smokers
will gradually reduce their physical dependence to
nicotine and the actual quitting will be easier. Nicotine
fading by itself actually has little impact on cessation
if the psychological component of the addiction is
not addressed, but it can be effective when combined
with other behavioral techniques (28).
Cue extinction is another method of preparing
for stopping smoking (29). The purpose and rationale
are to identify the cues associated with smoking, and
alter the social and psychological reinforcers that
trigger smoking behaviors. The actual quitting method
is cold turkey. Persons identify their favorite ritual
229
cigarettes or the cigarettes that are going to be the
hardest to give up, and eliminate them before they
quit. The rationale is that when a person quits, the
strongest urges have already been experienced and
will not be as difficult to overcome. This method also
allows for the identification of cues or trigger situations
that are strongly associated with smoking so that
alternative behaviors or ways to avoid these situations
can be planned before they quit.
The purpose of nicotine gum is to help decrease
the urge to smoke and minimize the withdrawal
symptoms while dealing with the psychological and
behavioral components of smoking. Studies indicate
that the long-term effectiveness of nicotine gum is
improved when it is used in combination with be-
havioral counseling (30). Instructions for proper use
are important (31,32). Nicotine gum should be
thought of as medication, and not gum. Nicotine
gum should be chewed very slowly. The gum should
be used on a regular schedule rather than waiting for
the urge to smoke. Nicotine gum is intended solely
for use while stopping smoking. It is not to be used
to cut down on cigarettes. The recommended length
of use is 3-6 months. Then a method of reduction
should be planned--either by decreasing the daily
amount by one piece of gum every week, cutting the
gum in half and using only half pieces, or alternating
nicotine gum with regular chewing gum. Nicotine
gum is contraindicated for pregnant women, patients
with oral or pharyngeal in8ammation, temporoman-
dibular joint disease, a history of esophagitis, peptic
ulcer, coronary heart disea.se, cardiac arrythmias, or
hypertension. Nicotine gum is considered to be more
useful for smokers who have a high physiological
dependence to nicotine-generally those who smoke
25 or more cigarettes a day and -those who have
experienced severe withdrawal symptoms in previous
quit attempts (23). Before prescribing nicotine gum,
it is important to assess individual physical addiction
to nicotine. The Fagerstrom nicotine tolerance scale
is a useful tool to determine the degree of nicotine
dependence (33). It includes questions that examine
smoking habits such as the number of cigarettes that
are smoked daily, the tar/nicotine rating of the brand
of cigarettes, when the first cigarette of the day is
smoked, and patterns of inhaling. The highest pbssible
score is l1; a score of Z7 indicates that a petson is
highly nicotine dependent.
Whatever method is utilized to quit smoking, a
critical factor for succest is selecting a quie date.
Setting the target date for quitting confirms the
cr,mmitment and is the most universally agreed upon
CeMa. NWsuW. t -rd. 1 t. No. S. 1991
I

230 at. A. ROSE
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
component of physician-delivered advice (7). It is
essential to prepare for the quit date by throwing
away cigarettes and smoking paraphernalia, and plan-
ning activities during the first few days with non-
smoking friends.
Maintenance
The third stage of becoming an ex-smoker is
maintenance. A period of 6 months must elapse
before a person is at relatively low risk of relapse (7).
There are several situations known to pose high risk
for the relapse of smoking (34). Social situations tend
to be particularly difficult times due to social drinking
and exposure to smoking. Times of relaxation such
as following a meal are strongly reinforced situations
for many people. Work can create smssful and
anxiety-producing situations, where in the past smok-
ing provided a tension release. Unusual life events,
such as vacations and holidays, can be difficult ex-
periences when faced for the first time as a nonsmoker.
Stressful life events such as a change of job, divorce,
death, or illness are high relapse situations.
How can these critical relapse situations be
effectively handled? Self-management techniques are
reinforcement systems that should be put in place
before quitting (17,18). Contracts can be written with
a friend - or family member to help get through
difficult times. A system of rewards, proportional to
the achievement, should be developed and utilized
for both short-term and long-term goals. It is impor-
tant that plans are made for immediate rewards that
can be personally reinforcing. Encourage individuals
to develop a buddy system or means of social support
with nonsmokers or friends who have quit. Provide
information on stress management techniques such
as deep breathing and relaxation exercises. Help
individuals to develop an appropriate physical exercise
or a weight gain management program. It is important
to discuss realistic exercise tolerance expectations and
avoid severe dietary re.sirictions; otherwise, adopting
all of these citanges at once can become overwhelming
and unsueaessful. Most important is the need for
individuals to identify and anticipate stressful situa-
tions and prepare for them in advance. A slip should
be thought of as a small setback and not a total
failure. Slips should be viewed as an opportunity to
learn what triggered the urge to smoke and to plan
for future similar situations.
SUMMARY
Oncology nurses can only be effective role models
and educators if we understand the methods that can
Caro NunirtC. Vol. 14, No. S. 1991
best assist individuals to stop smoking and if we
provide this assistance in a compassionate, but firm
approach. The vast majority of individuals who smoke
would like to quit; therefore, it is easy to identify
those who may require our assistance. We need to
continue to identify and develop effective interven-
tions, and determine what we can do to encourage
and assist persons who are at the "trying to quit"
stage. D
REFERENCES
1. The surgeon general's 1989 report on reducing the fieatth
consequences of smoldttg 25 years of progtesi VMti'R 1989;38
(Suppl S2).
2. U.SD.H.H.S., Office on Smoking and Health. The health
carts[quences of smoking: cancer. A reporr of tRe swgeoie
generaL Washington, DC DHHS (PHS) 82-50179. 1982.
3. American Cancer Society. Caruer,facts and frgures-1990. New
Yor(<: American Caneer Society, 1990.
4. U.S. Cot>aresa Office of Tecttnolop Assessment. Smoking-
re/ate,d deaths and financial costs. OTA Staff Memorandum.
Setnember 1985.
5. Fielding IE. Phenow KJ. Health effects of invoiuatuy smoking.
N Ertg/ J Med 1988:319:1452-60.
6. National Research Council. Committee on Psmive Smoicine.
Ertrhorvxerual tobacco snioke: measuring expo.tuns and as-
senirtg healgh effects. Wnhington. DC: National Academy
Press. 1986.
7. Gritz ER. Cigarette smoking: tne need for action by health
professionals. CA 1988;38:194-212.
8. Spitz MR. Fueger !J, Eriksen MP. Neweil GR. Profiles of
cigarette smoking among patients in a cancer center. J Cancrr
EdLc 1988;3:265-71.
9. Orleans CT. Lindblad A. Davis S. et al. The need for brief
physidan initiated quit smoking strategies in CCOP settings.
Ptaented at Advances in Canecr Control VIII. Bethesda, MD:
Marsls. 1990.
10. Davisnn G, Duffy M. Smoking habits of tong-term survivocs
of stu8ery for lung cancer. Thoros 1982:37:331-3.
11. Rose MA. Health promotion and risk prevention: applications
for cancer survivors. Oncol Nurs Forum 1989:16:335-dU.
12. Moore C. Cigatette smoking and cancer of the mouth. pharynx=
and Isryna. JAAlA 1971 Z 18:35 3-8.
13. Stevens MH. Gardnrr 1W, Parking 1L et al. Head and tkck
cancer survival and lifestyie chanae. : tndt Oto/arynaol 1983:109:
746-9.
14. Bullock C. Study 6nds smoking and obesity may increase
metata~s in older wotnen with breast canca. Oncol Timrs
1988:10:12-3.
15. Knudsen N. Schulman S. Van Den Hoelc J. Fowler R. Insights
on how to quit smoking: a survey of patients with lung cancer.
Cmtaer Ntus 1985:8:145-50.
16. Cullen !W. Strategia to stop smoking. In: Devita ,VT Jr.
Hdlman S. Rosenberg SA. eds. Cancer prevenrzon. Pt>lbtldphia,
PA: Lippncott. May, 1989: 1-12. !
17. Amerian Lung Association. Freedom from snrokrnR ~for You
and your famil.y. New York: American Lung Associaio#, 1987.
18. National Canxr Institute. Clearing the afr. Betltesd~ M"
NIH Publication 89-1647. 1989. ~ ~
19. Ametican Academy of Family Physicians. AMFP stop smdciV&
pnqrram. Kansas City, MO: American Academy of Fami~n
Physicians, 1987. ~
. O
~

I
I
I
I
I
I
I
I
1
I
I
I
I
I
I
I
I
INTERVEh77ON STR4TEGIES FOR SMOKING CESS4TION 231
20. Ockene JK Sachs DP. Solberg L. Sure-fire smoking cessation.
Pattent Care 1988L2-1:83-116.
21. Russell M.A. Wilson C, Taylor C. Baker CD. Effect of general
practttioners' advice against smoking. Br Med J 1979:2:231-5.
22. Taylor CB. Houston-Mi11-r N, Killen JD. DeBusk R.F. Smoking
cessation after acute myocardial infarction: effects of a nurse-
managed intervention. Ann lnternMed 1990:113:1 18-23.
23. Orleans CT. Smoking cessation in primary rare setting. NJ
Med 1988:85:116-26.
24. Hughes JR. Kottke T. Doctors helping smokers. Real world
tactics. Minn Med 1986:69Z93-5.
25. U.S.D.H.H.S., Office on Smoking and Health. The health
consequences of smolcing. ntcottne addiction. A report of the
surgeon general. Rockville. MD: DHHS (CDC) 88-8406, 1988.
26. Orieans CT. Undttstanding and promonn` smoking cessation:
overview and Euideiina for physician intervention. Annu Rev
Med 1985:36:51-61.
27. Ivetson DC. Smoking oontrol pnograms: premises and prontises
Am J Xealth Prom 1987;1:16-30.
28. Alexander L. Patient smoking cessation: treatment strategles.
Nurse Pract 1988:13:27-37.
29. Bishop D. French R. Rose MA. Smoking cessatton protocol
for pnmary care phvstcran's offices. NCI Concept xCCC-88-
008. July, 1988.
30. Kamarack TW. Lichtenstein E. Current trends in clinic-ba_sed
smoking control. Ann Behav Med 1985:7:19-23.
31. Schneider N. How to use nicotine gum and other strategies to
qutt smoking. New York: Simon and Schuster, 1988.
32. Oregon Health Sciences Unive:sity. A patient guide to nicotine
reduction therapy: how to use nicorette medicine. Portland,
OR: Oregon Health Sciences Univasity, 1989.
33. Fagerurom KO. Measuring degree of physial dependence to
tobacco smoking with ttference to individualiutton of treat-
ment. Addtct Behav 1978:3:235-41.
34. Schiffman S. A duster-analytic ciasrifiation of smoking telapse
epssodes. Addict Behav 1986;11:295-307.
Co+tte- NiasrW. tbl. 14. No. S. 1991
I
